GlassScriptPhysician profile
Larry D Foster
NPI 1477559060
$963.30
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $255 · 2021: $365.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $169.00 | 2019 | |
| Clarus Therapeutics INC. | $113.43 | 2021 | |
| Amarin Pharma, INC. | $100.49 | 2019-2020 | |
| Glaxosmithkline, LLC. | $97.95 | 2019-2021 | |
| Pfizer INC. | $82.44 | 2020-2021 | |
| Esperion Therapeutics, INC. | $66.89 | 2020-2021 | |
| Astellas Pharma US INC | $37.79 | 2019-2021 | |
| Allergan, INC. | $37.16 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.58 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $29.89 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.44 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $22.20 | 2021 | |
| Novo Nordisk INC | $20.24 | 2019 | |
| Aytu Biopharma, INC. | $18.15 | 2020 | |
| Lilly USA, LLC | $17.58 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.09 | 2019 | |
| Eisai INC. | $15.33 | 2021 | |
| Gilead Sciences, INC. | $14.79 | 2021 | |
| Welch Allyn | $14.08 | 2021 | |
| Merck Sharp & Dohme LLC | $13.58 | 2019 | |
| Amgen INC. | $12.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.